Ionis Pharmaceuticals Inc IONS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/28/24 EDT
43.35UNCH (UNCH)
Volume
100,582
Close
43.35UNCH (UNCH)
Volume
1,898,377
52 week range
33.32 - 54.44
Loading...
  • Open44.95
  • Day High44.95
  • Day Low43.32
  • Prev Close44.66
  • 52 Week High54.44
  • 52 Week High Date01/12/24
  • 52 Week Low33.32
  • 52 Week Low Date03/28/23

Key Stats

  • Market Cap6.318B
  • Shares Out145.75M
  • 10 Day Average Volume0.92M
  • Dividend-
  • Dividend Yield-
  • Beta0.39
  • YTD % Change-14.31

KEY STATS

  • Open44.95
  • Day High44.95
  • Day Low43.32
  • Prev Close44.66
  • 52 Week High54.44
  • 52 Week High Date01/12/24
  • 52 Week Low33.32
  • 52 Week Low Date03/28/23
  • Market Cap6.318B
  • Shares Out145.75M
  • 10 Day Average Volume0.92M
  • Dividend-
  • Dividend Yield-
  • Beta0.39
  • YTD % Change-14.31

RATIOS/PROFITABILITY

  • EPS (TTM)-2.56
  • P/E (TTM)-16.93
  • Fwd P/E (NTM)-10.84
  • EBITDA (TTM)-340.88M
  • ROE (TTM)-76.34%
  • Revenue (TTM)787.647M
  • Gross Margin (TTM)98.84%
  • Net Margin (TTM)-46.50%
  • Debt To Equity (MRQ)329.61%

EVENTS

  • Earnings Date05/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ionis Pharmaceuticals Inc

 

Profile

MORE
Ionis Pharmaceuticals, Inc. is engaged in ribonucleic acid (RNA)-targeted therapeutics. The Company has five marketed medicines and a pipeline in neurology, cardiology, and other areas of high patient need. It has nine medicines in Phase III development and multiple additional medicines in early and mid-stage development. The Company’s products include SPINRAZA, QALSODY, WAINUA, TEGSEDI and WAYLIVRA. SPINRAZA is used for the treatment of patients with spinal muscular atrophy...
Joseph Loscalzo M.D., Ph.D.
Independent Chairman of the Board
Brett Monia Ph.D.
Chief Executive Officer, Director
Elizabeth Hougen
Chief Financial Officer, Executive Vice President - Finance
Eric Swayze Ph.D.
Executive Vice President - Research
Eugene Schneider M.D.
Executive Vice President, Chief Clinical Development Officer
Patrick O'Neil Esq.
Chief Legal Officer, General Counsel and Corporate Secretary
Address
2855 Gazelle Court
Carlsbad, CA
92010
United States

Top Peers

SYMBOLLASTCHG%CHG
BPMC
Blueprint Medicines Corp
94.86UNCHUNCH
PBH
Prestige Consumer Healthcare Inc
72.56UNCHUNCH
CORT
Corcept Therapeutics Inc
25.19UNCHUNCH
AMPH
Amphastar Pharmaceuticals Inc
43.91UNCHUNCH
SUPN
Supernus Pharmaceuticals Inc
34.11UNCHUNCH